Abstract:Bioactive peptides derived from food are promising health-promoting ingredients that can be used in functional foods and nutraceutical formulations. In addition to potency towards the selected therapeutic target, the bioavailability of bioactive peptides is a major factor regarding clinical efficacy. We have previously shown that a low molecular weight peptide fraction (LMWPF) from poultry by-product hydrolysate possesses angiotensin-1-converting enzyme (ACE-1) and dipeptidyl-peptidase 4 (DPP4) inhibitory activity. The present study aimed to investigate the bioavailability of the bioactive peptides in the LMWPF. Prior to investigation of bioavailability, a dipeptide YA was identified from this fraction as a dual inhibitor of ACE-1 and DPP4. Gastrointestinal (GI) stability and intestinal absorption of the bioactive peptides (i.e., YA as well as two previously reported bioactive dipeptides (VL and IY)) in LMWPF were evaluated using INFOGEST static in vitro digestion model and an intestinal Caco-2 cell monolayer, respectively. Analysis of peptides after in vitro digestion confirmed that the dipeptides were resistant to the simulated GI conditions. After 4 hours of incubation, the concentration of peptide from the apical side of the Caco-2 cell monolayer showed a significant decrease. However, the corresponding absorbed peptides were not detected on the basolateral side, suggesting that the peptides were not transported across the intestinal monolayer but rather taken up or metabolized by the Caco2 cells.Furthermore, when analyzing the gene expression of the Caco-2 cells upon peptide stimulation, a down-regulation of peptide transporters, the transcription factor CDX2, and the tight junction protein-1 (TJP1) were observed, suggesting specific effects of the peptides on the Caco-2 cells. The study demonstrated that bioactive dipeptides found in LMWPF were stable through in vitro GI digestion, however, the overall bioavailability may be hindered by inadequate uptake across the intestinal barrier.

Evaluating intestinal absorption of peptide Met-Lys-Pro in casein hydrolysate using Caco-2 and human iPS cell-derived small intestinal epithelial cells

Identification and Analysis of Transepithelial Transport Properties of Casein Peptides with Anticoagulant and ACE Inhibitory Activities

Human Intestinal Caco-2 Cell Model to Evaluate the Absorption of 7-Ketophytosterols and Their Effects on Cholesterol Transport

Simultaneous Evaluation of Membrane Permeability and UDP-Glucuronosyltransferase–Mediated Metabolism of Food-Derived Compounds Using Human Induced Pluripotent Stem Cell–Derived Small Intestinal Epithelial Cells

Production And Transepithelial Transportation Of Casein-Derived Peptides And Identification A Novel Antioxidant Peptide Lhsmk

Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model

Bioavailability of Peptides from Casein Hydrolysate in Vitro: Amino Acid Compositions of Peptides Affect the Antioxidant Efficacy and Resistance to Intestinal Peptidases

Identification of Immune-Active Peptides in Casein Hydrolysates and Its Transport Mechanism on a Caco-2 Monolayer

Effects of Casein-Derived Peptide Met-Lys-Pro on Systolic and Diastolic Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

Evaluation of the multifunctional dipeptidyl-peptidase IV and angiotensin converting enzyme inhibitory properties of a casein hydrolysate using cell-free and cell-based assays

Structural Requirement of Casein Peptides for Transcytosis Through the Caco-2 Cell Monolayer: Hydrophobicity and Charge Property Affect the Transport Pathway and Efficiency

Transportation of whey protein-derived peptides using Caco-2 cell model and identification of novel cholesterol-lowering peptides

Properties and Regulation of Gly-Sar Uptake and Transport in Bovine Intestinal Epithelial Cells.

Hydrophobicity exerts different effects on bioavailability and stability of antioxidant peptide fractions from casein during simulated gastrointestinal digestion and Caco-2 cell absorption

Digested casein phosphopeptides impact intestinal calcium transport in vitro

In Vitro and in Silico Analysis of Dual-Function Peptides Derived from Casein Hydrolysate

In vitro gastrointestinal stability and intestinal absorption of ACE-1 and DPP4 inhibitory peptides from poultry by-product hydrolysate

Intestinal Absorption of Milk-Derived ACE Inhibitory Peptides LL and LPEW Using Caco-2 Cell Model

Analysis And Evaluation Of The Inhibitory Mechanism Of A Novel Angiotensin-I-Converting Enzyme Inhibitory Peptide Derived From Casein Hydrolysate

Preparation, Characterization and Iron Absorption by Caco-2 Cells of the Casein Peptides-Iron Chelate

Stimulation Of Gastric Transit Function Driven By Hydrolyzed Casein Increases Small Intestinal Carbohydrate Availability And Its Microbial Metabolism